rs146216425
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000322213.9(SMC1A):c.3591C>T(p.Ala1197=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000344 in 1,203,511 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 140 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1197A) has been classified as Likely benign.
Frequency
Consequence
ENST00000322213.9 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMC1A | NM_006306.4 | c.3591C>T | p.Ala1197= | synonymous_variant | 24/25 | ENST00000322213.9 | NP_006297.2 | |
SMC1A | NM_001281463.1 | c.3525C>T | p.Ala1175= | synonymous_variant | 25/26 | NP_001268392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMC1A | ENST00000322213.9 | c.3591C>T | p.Ala1197= | synonymous_variant | 24/25 | 1 | NM_006306.4 | ENSP00000323421 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000483 AC: 54AN: 111897Hom.: 0 Cov.: 22 AF XY: 0.000528 AC XY: 18AN XY: 34069
GnomAD3 exomes AF: 0.000800 AC: 146AN: 182458Hom.: 0 AF XY: 0.000672 AC XY: 45AN XY: 66936
GnomAD4 exome AF: 0.000330 AC: 360AN: 1091561Hom.: 0 Cov.: 30 AF XY: 0.000341 AC XY: 122AN XY: 357365
GnomAD4 genome AF: 0.000482 AC: 54AN: 111950Hom.: 0 Cov.: 22 AF XY: 0.000527 AC XY: 18AN XY: 34132
ClinVar
Submissions by phenotype
Congenital muscular hypertrophy-cerebral syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 23, 2014 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 21, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at